Antibodies to Porcine Uteroferrin Used in Measurement of Human Tartrate-Resistant Acid Phosphatase
Zeinep 0. Echetebu,13 Timothy M. Cox,2 and DonaldW. Moss1'4 The immunological similarity between human tartrate-resistant acid phosphatase (EC 3.1.3.2) and porcine uteroferrin previously reported for the, isoenzyme from spleens of patients With leukemic reticuloendotheliosis (Ketcham et at., J Blot Chem 1985 ;260:5768-76) has been confirmed for partly purified acid phosphatase found in the spleen of a patient with Gaucher's disease, and for the corresponding isoenzyme in other tissues and serum. Anti-uteroferrin antibodies raised in rabbits have been used to demonstrate the feasibility of their application in an immunoassay for tartrate-resistant acid phosphatase in serum.
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The tartrate-resistant isoenzyme of human acid phosphatase (EC 3.1.3.2) is expressed normally in certain differentiated cells of the mononuclear phagocyte system, notably osteoclasts (1) and alveolar macrophages (2, 3), and pathologically in Gaucher's cells (4) and the hairy cells of leukemic reticuloendotheliosis (5). Its specific normal and pathological expression gives this isoenzyme potential diagnostic value that has long been recognized, particularly for osteoclast-derived acid phosphatase. However, methods for measuring osteoclastic acid phosphatase in serum have largely depended on the use of its property of resistance to inhibition by d-tartrate in conventional assays of acid phosphataseactivity. These methods lackadequate sensitivity and specificity fordetecting small changes in the concentration of thisisoenzyme in serum. Although the distinctive isoenzymic properties of tartrate-resistant acid phosphatase imply a unique antigenic identity, this possibility has been exploited so far in only one assay, which involves using a rabbit antiserum raised against the isoenzyme purified from hairy-cell leukemic spleen (6) .
Not only is human tartrate-resistant acid phosphatase from hairy-cell leukemic spleen one of a class of widely distributed, iron-containing acid phosphatases, it also displays a high degree of immunological similarity with porcine uteroferrin, an iron-containing protein with acid phosphatase activity, which is abundant in porcine uterine secretions (7) . Antiseratoporcineuteroferrin therefore offer an alternative approach to the immtmoassay of tartrateresistant acid phosphatase.
Here we show that acid phosphatases from spleen of patients with Gaucher's disease, or from normal lung and from sera of patients with bone disease, also cross react with anti-uteroferrin antisera. We also report experiments demonstrating the feasibility of an assay for this isoenzyme based on the use of anti-uteroferrin antibodies.
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Materials and Methods

Materials
Uteroferrin:
Pure porcine uteroferrin (8) Tartrate-resistant (typeS) acid phosphatase was partly purified from spleen from a patient with Gaucher's disease, essentially as was described for purification from hairy-cell leukemic spleen by Ketcham et al. (7) . However, after the gel-filtration through Sephadex G200 (Pharmacia, Uppsala, Sweden), we used affinity chromatography on a column of concanavalin A-Sepharose
4B
(volume about 5 mL) instead of immunoaffinity chromatography, eluting with 30 mL of a-methyl-n-mannoside (500 mmol/L) in acetate buffer (10 mmollL, pH 6.5) containing, per liter, 350 mmol of NaCI, 1 mmol each of MgCI2, MnC12, and CaCl2,and 300 g ofethyleneglycol.
The final volume (31 mL) obtained from 500 g of spleen contained 1.1 mg of protein and 95 U of acid phosphatase activity per liter (specific activity, 85 kU per gram of protein). Only 5% of the activity was inhibited by d-tartrate. This specific activity is slightly less than that achieved by Ketcham et al. (7) at the same stage (approx. 110 kU/g, allowing for the different methods of assay), but we also experienced considerable losses during purification: our overall recovery was <10%.
Human lung and prostate tissue, obtained at autopsy, and placenta were extracted as previously described (2). A solution of erythrocytic acid phosphatase was obtained by lysing erythrocytes in water. Because of the lack of availability of suitable samples of human bone, we used sera from patients with increased tartrate-resistant acid phosphataseactivity (duetoPaget's disease ofbone)as sourcesof the osteoclast isoenzyme ("bone-disease serum").
Procedures
Measuring en.zyrne activity: We measured acid phosphatase activity by an automated, continuous-monitoring assay based on the Hillmann procedure, with 1-naphthyl phosphate as substrate at pH 5.6, 37 #{176}C (9), with or without addition of d-tartrate (40 mmol/L). In some experiments, e.g., when attempting to determine the amount of antibodybound enzyme, we used a fixed incubation with 4-nitrophenyl phosphate. All activities are expressed as micromoles of substrate hydrolyzed per minute (U).
Immunization schedule:
New Zealand White rabbits (3 kg) were immunized by combined intradermal, subcutaneous, and intramuscular injection of proteins in aqueous solution emulsified with equal volumes of Freund's adjuvant. Uteroferrin antiserum was obtained by inoculation with 1 mg of protein in Freund's complete adjuvant, followed by another1 mg similarly fourweeks later. A further inoculation of0.4mg ofuteroferrin in incompleteadjuvant was made after anothersixweeks, and serum was obtained two weeks later. was heated at 56 #{176}C for 30 mm and clarified by centrifugation beforeuse. Nonimmune rabbit serum was treated identically before use as a carrier.
Specific anti-uteroferrin antibody was purified from serum by affinity chromatography on columns containing uteroferrin-Sepharose 4B. Porcineuteroferrin (5 mg) was covalently coupled to 2.5 mL of swollen CNBr-activated agarose gel (Sepharose CNBr-CL4B, Pharmacia) at >90% efficiency, as recommended by Pharmacia. We diluted 100 mL of de-complemented antiserum with an equal volume of phosphate-buffered saline (PBS; NaC1 9 g/L, pH 7.4) containing 5 imnol of EDTA per liter; we then added 5000 kallikrein-inhibitory units of aprotinin (Bayer). The antiserum was twice passed through a column of uteroferrinSepharose (2.5mL ofgel), being elutedat a flowrateof 20 mL/h with 20 mL of PBS, followed by 10 mL of diluted PBS (equal volumes of PBS and water). Purified antibody was eluted from the column by addition of 10 mL of 20 g/L acetic acid solution. After neutralization with Tris base, the antibody was retrieved by dialysis, then precipitated with saturated (NH4)2S04 at 4#{176}C and centrifuged. We dissolved the pellet of antibody in the minimum volume of water and filtered this through a Sephadex G25 column (PD 10;
Pharmacia) equilibrated with a solution containing 500 mmol of NaC1 and 100 mmol of NaHCO3 per liter, pH 8.6. Assuming the absorbance of a 10 gIL solution of rabbit IgG in a 1-cm light path to be 14, we calculated the yield of purified antibody by this procedure as approximately 5 mg.
Other procedures. We prepared anti-uteroferrin-Sepharose by coupling the antibody to CNBr-activated Sepharose CL 4B, as described above for the antigen-coupled gel. 
Results
Preparation and Characterization of Antiserum
Acid phosphatase purified from Gaucher's disease spleen proved to be only weakly antigenic when injected into the rabbit, presumably because of the low absolute amount of antigen protein in each injection. At most, only 20% of acid phosphatase added to serum was precipitated by this antiserum. With porcine uteroferrin as the immunogen, on the other hand, the antiserum produced by six weeks after the start of immunization could precipitate 90% of added acid phosphatase ( Figure 1 ).
Titration curves for increasing amounts of spleen acid phosphatase added to human serum, as determined with two fixed volumes (20 or 40 tL) of antiserum obtained two weeks after the final inoculation, indicated that 1 z.L of the antiserum was capableof precipitating about 1.25mU of enzyme ( Figure 2 ). The rabbit anti-uteroferrin serum was further characterized by Western blot analysis. An extract of Gaucher's disease spleen, uteroferrin, and partly purified spleen acid phosphatase separated in sodium dodecyl sulfate-containing gels were probed with antiserum. After washing the gels, we used imIlabe1ed Protein A to detect the immunoreactive species. In addition to the strong radioactive bands formed between the antisera and uteroferrin, bands of correspondAnti-uteroferrin antiserum (iL) Fig. 1 . Precipitation of partly purified acid phosphatase from Gaucher's disease spleen by increasing volumes of rabbit antiserum to porcine uterofernn (obtained six weeks after the start of immunization)
We added 54 mU of acid phosphatasein a total volumeof 525 pL in Tris buffer, pH 8.2. After incubation overnight at 4 C, followed by centnfugation, acid phosphatase activitywas measuredin the supemate; the amount precipitated was calculated as the differencebetween the added activity and the activity remainingin the supemate Activitiesare expressedas U/L in thesupemate, before (0) and after (#{149}) precipitation as in Fig. 1 ; 0, % activityprecipitated. Substrate:1-naphthyl phosphate ing mobility were also present in the spleen extract and in the solution of purified tartrate-resistant acid phosphatase (Figure 3) . The estimated molecular mass of 35 000 Da for spleen acid phosphatase was in good agreement with our previous estimates of 37 000 for the isoenzyme prepared from bone and lung (2).
Ouchterlony immunodiffusion
showed that the antiserum did not cross react with acid phosphatase-containing extracts of human erythrocytes or prostate (Figure 4 ) or with the placental extract used as a source of lysosomal acid phosphatase. Activities in serum from patients with bone Fig. 3 . Western immunoblots of partly purified acid phosphatase from Gaucher's disease spleen (ACP; two center lanes, at different concentrations), the unfractionated spleen extract, and pure porcine uteroferrin (UF) The blot has been overexposed with respect to uterofemnto detect possible cross-reactingbands in the unfractionatedspleen extract.The immunoreactive species were located with anti-uteroferrin antiserum, followed by '251-labeled proteinA. The anodaldirectionis downwards disease and in lung extract were too low to give well-defined precipitin arcs. However, Sepharose-bound anti-uteroferrin antibodies (see below) quantitatively precipitated tartrateresistant acid phosphatase from bone-disease serum, and also from an extract of human lung. The respective acid phosphatase activities (total, tartrate-resistant, and immunoprecipitated) were: bone-disease serum, 6.5, 5.3, and 5.3 U/L; lung extract, 13.8, 12.0, and 11.8 U/L. Under the same conditions no activity was precipitated from an extract of prostate (acid phosphatase 1202 U/L) or erythrocytes (acid phosphatase 37 U/L, with 4-nitrophenyl phosphate substrate).
Use of Antiserum in Assays of Tartrate-Resistant Acid Phosphatase
The availability of an antiserum reacting specifically with human tartrate-resistant acid phosphatase allowed different designs of immunoassays to be tested: e.g., assays in which antibody-reactive activity is measured directly in the precipitate or bound to a solid phase, or assays in which the activity in the supernate is measured before and after reaction with antibody. An immunoassay in which the specific isoenzyme isseparated by precipitation with antiserum and its activity determined in the precipitate allows the concentration of the analyte to be increased and so would be expected to offer greater sensitivity and precision than one in which the specific isoenzyme is determined from the difference between the total activity and the activity in the supernate after immunoprecipitation.
Therefore, we first tested two immunoprecipitation assays, one with whole antiserum and one with Sepharose-bound purified antibodies.
We examined the correlation between added spleen acid phosphatase activity and the activity accounted for by resuspending the immunoprecipitate obtained with rabbit anti-uteroferrin antiserum. However, we could account for no more than 33%, less at low added activities ( Figure 5 ). of spleen acid phosphatase (7) . We therefore explored the use of purified antibodies bound to this matrix in an immunoprecipitation assay. After precipitation and centrifugation, bound acid phosphatase activity was eluted from the matrix with glycine-HC1 buffer, 50 mmolIL, pH 2.3, containing 150 mmol of NaC) per liter (7). However, as reported previously (7), recoveries of bound acid phosphatase activity were low.
Therefore, we did not explore this type of assay further and directed our attention to the assay of activities in solution before addition of antibody and in the supernate after precipitation.
Sepharose-bound anti-uteroferrin antibodies were suspended in four volumes of Tris buffer (10 mmol/L, pH 8.2, containing NaCl, 300 mmol!L). We added 0.3-mL portions of the suspension to 0.4 mL of the same buffer in glass centrifuge tubes with conical bottoms, then added 0.3 mL of a serum pool to which purified spleen acid phosphatase had been added to give various concentrations of activities. After mixing,
we let the samples stand at 4 00 for 2 h, with occasional shaking.We then centrifuged them (1000 x g, 10 mm) and quantified the acid phosphatase activity in 0.5 mL of each supernate by using 1-naphthylphosphate as substrate, at 37 #{176}C. The isoenzyme activity before precipitation was measured by diluting each sample to the same total volume, but without adding the antibody suspension. To measure nonspecific precipitation, we prepared controls to unprecipitatedcontrolsamples (6)measures activity in the precipitate after precipitation with an antiserum raised against the isoenzyme from hairycontain four concentrations of activity within the same cell leukemic spleen: however, only 42% of the activity was range, by replacing the specific antibodies with Sepharoserecoverable in the precipitate. bound nonimmune rabbit IgG.
We have measured acid phosphatase activity in the assay Recovery, calculated as the difference between total activby the automated modified Hillmann procedure used in our ity and activity in the supernate after precipitation, varied laboratory, to gain the advantages of a continuous monitorlinearly with the added spleenacid phosphatase activity, ingmethod.The sensitivity ofthe immunoassay incorporatexpressed in U per liter of sample ( Figure 6 ). The slope of mg this method seems adequate at the upper reference limit the regression line was 0.93; the y-intercept (0.47 U/L), for the tartrate-resistant acid phosphatase of serum from which was significantly different from zero (P <0.05), probaadults (about 5 U/L), as estimated for the same method of bly resulted from a slight under-correction for the endogeactivity measurement and with addition of d-tartrate to nous acid phosphatase activity of the serum poo1 (total improve isoenzyme specificity (9) . However, 1-naphthyl activity 2 U/L, including 1.5 U of tartrate-sensitive activity phosphateislessrapidlyhydrolyzed by the tartrate-resistper liter). Nonspecific precipitation by Sepharose-bound IgG ant isoenzyme than is 4-nitrophenyl phosphate, and the averaged 7% over the activity range. Between-run precision linear molar absorptivity of the reaction product in the estimated from duplicate samples analyzed on separate days Hillmann procedure (15.6 i03 L . mol' cm 1) is rather gave a CV of 8.7% for a mean activity of 9.9 UIL (n = 8).
less than that of 4-nitrophenol (18.6 iO L mol cm1).
Therefore, sensitivity could be increased, presumably, by using the latter substrate in a fixed-incubation procedure. The amount of Sepharose-bound antibody used is adequate to bind all tartrate-resistant acid phosphatase in serum up to five times the upper reference limit, at least. The highest activity of this isoenzyme that we have observed was 21 U/L in the serum of a patient with osteopetrosis; 1-naphthyl phosphate was the substrate. 
